IDegAsp is a co-formulation of long-acting basal (insulin degludec) and rapid-acting bolus (insulin aspart) insulin (70:30 ratio) and is one of the most often described pre-mix formulations worldwide.1

Once-daily treatment with IDegAsp and IAsp as bolus insulin for remaining meals is associated with significantly lower risk of nocturnal confirmed hypoglycaemia, improved glycaemic control.

Please sign in to read more